Multiplexed Diagnostics Market Expected to Reach $41.5 Billion by 2032

Multiplexed diagnostics market size was valued at $10.7 billion in 2022, and is estimated to reach $41.5 billion by 2032, growing at a CAGR of 14.5% from 2023 to 2032. Multiplexing is the ability to identify a broad spectrum of conditions in a single molecular diagnostic test procedure, as opposed to conducting discrete individual procedures. It enables a single test to identify numerous conditions, attributes, or genetic sequences simultaneously, including those belonging to cancer genes, a bacteria or virus in humans, animals or the food distribution supply chain, or specific attributes of a seed variety.

𝐋𝐢𝐬𝐭 𝐨𝐟 𝐊𝐞𝐲 𝐏𝐥𝐚𝐲𝐞𝐫𝐬 :
Illumina Inc., Agilent Technologies, Inc., F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., BioMerieux SA, Diasorin S.p.A., Co-Diagnostics, Inc., Bio-Rad Laboratories Inc, Hologic Inc., Siemens Healthineers AG

𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐒𝐚𝐦𝐩𝐥𝐞 𝐑𝐞𝐩𝐨𝐫𝐭 https://www.alliedmarketresearch.com/request-sample/15809

On the basis of product type, the multiplexed diagnostics market analysis is segmented into instruments & accessoris and kits & reagents. The kits & reagents segment generated maximum revenue in 2022, owing to surge in demand for personalized medicine and advancements in multiplexed diagnostic. However, the instruments & accessories segment is expected to witness a significant CAGR during the forecast period.

On the basis of application, the infectious disease segment dominated the market in 2022, owing to rising burden of infectious diseases and the ability of multiplexed diagnostics test to simultaneously detect and quantify multiple biomarkers for diagnosing complex diseases. The autoimmune disease segment is expected to witness a significant CAGR during the forecast period.

On the basis of end user, the hospitals segment dominated the market in 2022, owing to upsurge in collaboration between diagnostic companies and hospitals and rise in the incidence of chronic disease. The diagnostic centers segment is expected to witness a significant CAGR during the forecast period.

On the basis of region, North America generated maximum revenue in 2022 owing to presence of advanced healthcare infrastructure, increasing prevalence of chronic diseases such as cancer, diabetes, and cardiovascular diseases that has driven the demand for advanced diagnostic tools and supportive regulatory agencies such as the U.S. FDA that have established clear pathways for the approval and commercialization of multiplexed diagnostic tests, providing a conducive environment for companies to develop and market multiplexed diagnostics products.

𝐅𝐨𝐫 𝐏𝐮𝐫𝐜𝐡𝐚𝐬𝐞 𝐈𝐧𝐪𝐮𝐢𝐫𝐲 https://www.alliedmarketresearch.com/purchase-enquiry/15809

However, Asia-Pacific is expected to provide the better multiplexed diagnostics market opportunity and witness the highest CAGR during the forecast period owing to large patient population, increase in healthcare infrastructure and increase in collaborations between domestic and international research institutions, along with partnerships with global biotech companies, for the development and advancement of multiplexed diagnostic technologies.

𝐕𝐀𝐋𝐔𝐄 𝐏𝐑𝐎𝐏𝐎𝐒𝐈𝐓𝐈𝐎𝐍𝐒 𝐑𝐄𝐋𝐀𝐓𝐄𝐃 𝐓𝐎 𝐓𝐇𝐄 𝐑𝐄𝐏𝐎𝐑𝐓:

Powered with Complimentary Analyst Hours and Expert Interviews with Each Report

Comprehensive quantitative and qualitative insights at segment and sub-segment level

Covid 19 impact trends and perspective

Granular insights at global/regional/country level

Deep-rooted insights on market dynamics (drivers, restraints, opportunities) and business environment

Blanket coverage on competitive landscape

Winning imperatives

Exhaustive coverage on 'Strategic Developments' registered by leading players of the market

Contact:

David Correa
5933 NE Win Sivers Drive
205, Portland, OR 97220
United States
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com

About Us

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

Pawan Kumar, the CEO of Allied Market Research, is leading the organization toward providing high-quality data and insights. We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

This release was published on openPR.